EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Design, Synthesis, and Evaluation of Coumarin‐Rasagiline Hybrids as Multifunctional Neuroprotective Agents

Aitor Carneiro, Sandra Barreiro, Claudia Sofia Machado, Miguel Pinto, Daniel Chavarria, Manuel Novás, Davide Crucitti, Carlos Fernandes, Maria João Matos iD

ChemMedChem · 27.05.2026 · 21 (10)

DOI: 10.1002/cmdc.70307 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 18.05.2026. Verfasst von Aitor Carneiro und 8 weiteren Autor:innen. Beteiligte Einrichtung: Departamento Química Orgánica, Facultad de Farmacia, Universidade de Santiago de Compostela, Santiago de Compostela, Spain. Hauptthemen laut MEDLINE: Coumarins, Neuroprotective Agents, Drug Design, Indans. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Foundation for Science and Technology (FCT) and FEDER/COMPETE, Xunta de Galicia, Fundação para a Ciência e a Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The design of hybrid molecules with multifunctional profiles has emerged as a promising strategy in medicinal chemistry, particularly for tackling complex disorders such as neurodegenerative diseases. There is an urgent need for therapeutic agents capable of acting on multiple pathological targets to both control neuronal death and support the recovery of already compromised neuronal populations. In this study, we synthesized and evaluated a series of hybrid compounds combining a coumarin scaffold with an alkynylamine moiety inspired by rasagiline. These molecules were studied for their potential as human monoamine oxidase ( h MAO) inhibitors, antioxidants, and neuroprotective agents. Five compounds demonstrated inhibitory activity against h MAO‐B in the micromolar range, along with significant neuroprotective effects against oxidative stress induced by Fe 3+ (FeNTA), tert ‐butyl hydroperoxide ( t ‐BHP), and hydrogen peroxide (H 2 O 2 ). Additionally, all compounds exhibited the ability to scavenge free radicals (ABTS assay) and chelate Fe(II), further corroborating their antioxidant capacity. In addition, the absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties were investigated. Docking studies and molecular dynamics simulations provide additional support for the experimental data. Collectively, these findings provide renewed evidence for the therapeutic potential of coumarin‐rasagiline hybrids as multifunctional agents for the treatment of neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CoumarinsNeuroprotective AgentsDrug DesignIndansMonoamine Oxidase InhibitorsHumansMonoamine OxidaseStructure-Activity RelationshipMolecular Docking SimulationOxidative StressMolecular StructureHydrogen PeroxideAntioxidantsDose-Response Relationship, DrugAnimals

Stichwörter der Autor:innen

coumarinhuman monoamine oxidasehybrid compoundsneurodegenerative diseasesneuroprotectionrasagiline

Substanzen

CoumarinsrasagilineNeuroprotective AgentsIndansMonoamine Oxidase InhibitorsMonoamine OxidasecoumarinHydrogen PeroxideAntioxidants

Autor:innen und Institutionen

  • Departamento Química Orgánica, Facultad de Farmacia, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
  • Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, Portugal.
  • Associate Laboratory i4HB - Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, Porto, Portugal.
  • UCIBIO - Applied Molecular Biosciences Unit, REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal.
  • RISE-Health, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Group of Computational Genomics and Hematology (GreCoXen), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.

ORCID-Profile: Maria João Matos

Förderung

  • Foundation for Science and Technology (FCT) and FEDER/COMPETE
  • Xunta de Galicia
  • Fundação para a Ciência e a Tecnologia

Zitieren

APA

Carneiro, A., Barreiro, S., Machado, C. S., Pinto, M., Chavarria, D., Novás, M., Crucitti, D., Fernandes, C., & Matos, M. J. (2026). Design, Synthesis, and Evaluation of Coumarin‐Rasagiline Hybrids as Multifunctional Neuroprotective Agents. ChemMedChem, 21(10). https://doi.org/10.1002/cmdc.70307

Vancouver

Carneiro A, Barreiro S, Machado CS, Pinto M, Chavarria D, Novás M, et al. Design, Synthesis, and Evaluation of Coumarin‐Rasagiline Hybrids as Multifunctional Neuroprotective Agents. ChemMedChem. 2026;21(10). doi:10.1002/cmdc.70307

BibTeX
@article{Carneiro2026,
  author = {Carneiro, Aitor and Barreiro, Sandra and Machado, Claudia Sofia and Pinto, Miguel and Chavarria, Daniel and Novás, Manuel and Crucitti, Davide and Fernandes, Carlos and Matos, Maria João},
  title = {Design, Synthesis, and Evaluation of Coumarin‐Rasagiline Hybrids as Multifunctional Neuroprotective Agents},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {10},
  doi = {10.1002/cmdc.70307}
}
Kostenlos starten →